Changeflow GovPing Healthcare & Life Sciences Stage I ACES Dementia Trial, Black Immigrants, ...
Routine Notice Added Final

Stage I ACES Dementia Trial, Black Immigrants, Apr 23

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

This Stage I trial will examine if a culturally adapted ACES intervention affects cognitive appraisal and behavioral activation among Black immigrants living with dementia and their care partners over a 1-month and 3-month period. The trial, sponsored by NIH, studies the Active Caregiving: Enhancing Skills intervention targeting this specific population. While trial registrations do not create direct compliance obligations, researchers and care organizations focusing on dementia in minority populations should note this trial for potential recruitment, partnership, or evidence-generation opportunities.

“This stage I trial will examine if the culturally adapted ACES intervention affects cognitive appraisal (self-efficacy and dysfunctional thoughts) and behavioral activation with Black immigrant living with dementia and their care partners over a 1-month and 3-month period”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Black Immigrant Project

N/A NCT07546708 Kind: NA Apr 23, 2026

Abstract

This stage I trial will examine if the culturally adapted ACES intervention affects cognitive appraisal (self-efficacy and dysfunctional thoughts) and behavioral activation with Black immigrant living with dementia and their care partners over a 1-month and 3-month period.

Conditions: Dementia

Interventions: Active Caregiving: Enhancing Skills

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Hospitals & Health Systems
Activity scope
Clinical trial registration Dementia research participation
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Healthcare Public Health Mental Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!